Amarin dealt blow as Supreme Court upholds 'skinny labels' for generics
Source: SeekingAlpha
2026-06-04 13:46:52 ET
More on Amarin
- Amarin Corporation plc (AMRN) Q1 2026 Earnings Call Transcript
- Amarin expects $70M in operating expense savings by June 30, 2026 while targeting positive 2026 cash flow
- Amarin GAAP EPS of -$0.03 misses by $0.04, revenue of $45.1M beats by $1.33M
- Seeking Alpha’s Quant Rating on Amarin
- Historical earnings data for Amarin
Read the full article on Seeking Alpha
For further details see:
Amarin dealt blow as Supreme Court upholds 'skinny labels' for generics
Liquidia Corporation
NASDAQ: LQDA
LQDA Trading
21.73% G/L:
$66.17 Last:
2,617,784 Volume:
$55.14 Open:
LQDA Latest News
May 27, 2026 08:30:00 am
Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference
May 13, 2026 12:43:57 pm
What to Know About This Fund's $15.5 Million Sale of Liquidia as Shares Skyrocket Nearly 260%
LQDA Stock Data
$3,502,438,146
63,941,680
1.04%
70
N/A
Biotechnology & Life Sciences
Healthcare
US
Morrisville
